Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease

GLIA

Volumn 61, Issue 10, 2013, Pages 1645-1658

  Virgone Carlotta, Angélique ^a   Uhlrich, Josselin ^a   Akram, Muhammad Numan ^a   Ressnikoff, Denis ^b   Chrétien, Fabrice ^c   Domenget, Chantal ^d   Gherardi, Romain ^c   Despars, Geneviève ^d   Jurdic, Pierre ^d   Honnorat, Jérôme ^a   Nataf, Serge ^a,b,e   Touret, Monique ^a,b  

^a LYON NEUROSCIENCE RESEARCH CENTER   (France)

^b UNIVERSITÉ LYON 1   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d UNIVERSITÉ DE LYON   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Dopamine; Neurodegeneration; Neuroinflammation; Substantia nigra

Indexed keywords

OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MAPPING; CELL CONTACT; CELL KINETICS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOFLUORESCENCE; MICROGLIA; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

DOPAMINE; NEURODEGENERATION; NEUROINFLAMMATION; SUBSTANTIA NIGRA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADRENERGIC AGENTS; ANIMALS; ANTIGENS, DIFFERENTIATION; APOMORPHINE; CELL COMMUNICATION; CELL COUNT; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; FEMALE; GREEN FLUORESCENT PROTEINS; IMAGING, THREE-DIMENSIONAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MICROSCOPY, CONFOCAL; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RECEPTORS, INTERLEUKIN-8A; ROTATION; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 84882864354     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22546     Document Type: Article

References (53)

1. Bessis A, Béchade C, Bernard D, Roumier A. 2007. Microglial control of neuronal death and synaptic properties. Glia 55:233-238.
2. Biber K, Vinet J, Boddeke HW. 2008. Neuron-microglia signaling: chemokines as versatile messengers. J Neuroimmunol 198:69-74.
3. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917-924.
4. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M. 2009. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909-913.
5. Colonna M. 2003. DAP12 signaling: From immune cells to bone modeling and brain myelination. J Clin Invest 111:313-314.
6. Colonna M. 2003. TREMs in the immune system and beyond. Nat Rev Immunol 3:445-453.
7. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758.
8. De Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. 2007. Neuronal chemokines: Versatile messengers in central nervous system cell interaction. Mol Neurobiol 36:137-151.
9. Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH. 2003. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci 18:2731-2742.
10. Fouillet A, Levet C, Virgone A, Robin M, Dourlen P, Rieusset J, Belaidi E, Ovize M, Touret M, Nataf S, Mollereau B. 2012. ER stress inhibits neuronal death by promoting autophagy. Autophagy 8:915-926.
11. Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M. 2012. Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport. Ann Neurol: 72:517-524.
12. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J. 2010. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 13:411-413.
13. Gao HM, Liu B, Zhang W, Hong JS. 2003. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 17:1954-1956.
14. Gerdes HH. 2009. Prions tunnel between cells. Nat Cell Biol 11:235-236.
15. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 166:3717-3723.
16. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. 2003. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol 170:2302-2309.
17. Hines DJ, Hines RM, Mulligan SJ, Macvicar BA. 2009. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 57:1610-1618.
18. Hirsch EC, Hunot S, Damier P, Faucheux B. 1998. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration? Ann Neurol 44:S115-S120.
19. Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA, Ali SF, Zhang J, Block ML, Hong JS. 2008. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol 181:7194-7204.
20. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI. 2012. Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287:19440-19451.
21. Kurkowska-Jastrzebska I, Wrońska A, Kohutnicka M, Czlonkowski A, Czlonkowska A. 1999. The inflammatory reaction following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50-61.
22. Lanier LL. 2009. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 227:150-160.
23. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Valina LD, Dawson TM, Przedborski S. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 12:1403-1409.
24. Linnartz B, Neumann H. 2013. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia 61:37-46.
25. Marín-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. 2004. Microglia promote the death of developing Purkinje cells. Neuron 41:535-547.
26. Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT. 2009. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: A time course study in a 6-hydroxydopamine model of Parkinson's disease. J Neurochem 110:966-975.
27. Maia S, Arlicot N, Vierron E, Bodard S, Vergote J, Guilloteau D, Chalon S. 2012. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Synapse 66:573-583.
28. McGeer PL, Itagaki S, Boyes BE, McGeer EG. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291.
29. McGeer PL, Yasojima K, McGeer EG. 2001. Inflammation in Parkinson's disease. Adv Neurol 86:83-89.
30. Meissner KK, Kirkham DL, Doering LC. 2005. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. Brain Res 1057:105-112.
31. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. 2007. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27:3328-3337.
32. Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, Chereul E, Langlois JB, Dumontel C, Cavillon G, Confavreux C, Mazzorana M, Vico L, Belin MF, Vivier E, Tomasello E, Jurdic P. 2005. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 166:275-286.
33. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
34. Onfelt B, Purbhoo MA, Nedvetzki S, Sowinski S, Davis DM. 2005. Long-distance calls between cells connected by tunneling nanotubules. Sci STKE 313:pe55.
35. Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T, Tassi I, Takai T, Stanley SL, Miller M, Shaw AS, Colonna M. 2009. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol 10:734-743.
36. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-1458.
37. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press
38. Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM. 1995. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647.
39. Rodrigues RW, Gomide VC, Chadi G. 2001. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci 109:91-126.
40. Rodriguez-Pallares J, Parga JA, Muñoz A, Rey P, Guerra MJ, Labandeira-Garcia JL. 2007. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem 103:145-156.
41. Roumier A, Béchade C, Poncer JC, Smalla KH, Tomasello E, Vivier E, Gundelfinger ED, Triller A, Bessis A. 2004. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci 24:11421-11428.
42. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. 2012. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691-705.
43. Schafer DP, Lehrman EK, Stevens B. 2013. The "quad-partite" synapse: Microglia-synapse interactions in the developing and mature CNS. Glia 61:24-36.
44. Schober A. 2004. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318:215-224.
45. Sisková Z, Page A, O'Connor V, Perry VH. 2009. Degenerating synaptic boutons in prion disease: Microglia activation without synaptic stripping. Am J Pathol 175:1610-1621.
46. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. 2002. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease. FASEB J 16:1474-1476.
47. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. 2006. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: Role of TNF-alpha. FASEB J 20:670-682.
48. Tremblay MÈ, Lowery RL, Majewska AK. 2010. Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8:e1000527.
49. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. 2009. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29:3974-3980.
50. Wakselman S, Béchade C, Roumier A, Bernard D, Triller A, Bessis A. 2008. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci 28:8138-8143.
51. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. 2011. Epidemiology and etiology of Parkinson's disease: A review of the evidence. Eur J Epidemiol 26:S1-S58.
52. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
53. Yamada J, Nakanishi H, Jinno S. 2011. Differential involvement of perineuronal astrocytes and microglia in synaptic stripping after hypoglossal axotomy. Neuroscience 182:1-10.